Detailed Information on Publication Record
2022
Impact of SARS-CoV-2 variants on the incidence of paediatric inflammatory multisystem syndrome (PIMS-TS)
DAVID, Jan, Ondrej HRADSKY, Petr JABANDŽIEV, Eva KLASKOVA, Helena JIRINCOVA et. al.Basic information
Original name
Impact of SARS-CoV-2 variants on the incidence of paediatric inflammatory multisystem syndrome (PIMS-TS)
Authors
DAVID, Jan (203 Czech Republic, guarantor), Ondrej HRADSKY (203 Czech Republic), Petr JABANDŽIEV (203 Czech Republic, belonging to the institution), Eva KLASKOVA (203 Czech Republic), Helena JIRINCOVA (203 Czech Republic) and Jan LEBL (203 Czech Republic)
Edition
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, HOBOKEN, WILEY, 2022, 1034-4810
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30209 Paediatrics
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 1.700
RIV identification code
RIV/00216224:14110/22:00128210
Organization unit
Faculty of Medicine
UT WoS
000862425800040
Keywords in English
SARS-CoV-2 variants; paediatric inflammatory multisystem syndrome
Tags
International impact, Reviewed
Změněno: 2/2/2023 14:40, Mgr. Tereza Miškechová
Abstract
V originále
In Spring 2020, following temporary success during the first wave of the world-wide pandemic of the novel 2019 coronavirus disease (COVID-19) with very few positive cases, the Czech Republic (CZ) subsequently suffered from one of the highest incidences of individuals who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In March 2022, the cumulative number of positive cases reached almost 3.5 million (34.1% of the population). Individual pandemic waves in CZ were characterised with predominant genetic variants, namely: B.1.258 in the second wave in late 2020, alpha (B.1.1.7) in the third wave in early 2021, delta (B.1.617.2) in the fourth wave in late 2021, and finally Omicron (B.1.1.529) in the last wave in early 2022. At the same time, paediatricians faced paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS). The incidence of PIMS-TS among SARS-CoV-2 positive children varies at around 0.3:1000. However, no data have been published on the impact of variants or lineages of SARS-CoV-2 on the occurrence of PIMS-TS. The aim of this study was to analyse the association between SARS-CoV-2 lineage and the incidence of PIMS-TS cases.